ID

39317

Descrição

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01476787

Link

https://clinicaltrials.gov/show/NCT01476787

Palavras-chave

  1. 19/12/2019 19/12/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

19 de dezembro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Follicular Lymphoma NCT01476787

Eligibility Follicular Lymphoma NCT01476787

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
Descrição

Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0441800
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0432516
have no prior systemic treatment for lymphoma
Descrição

Systemic therapy Absent Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0024299
symptomatic follicular lymphoma requiring treatment.
Descrição

Follicular Lymphoma Symptomatic Treatment required for

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0332121
age ≥18 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group performance status 0-2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow pregnancy precautions
Descrição

Contraceptive methods Willing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
Descrição

Lymphoma transformation | Follicular Lymphoma Grade

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0040682
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0441800
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
Descrição

Major surgery | Exception Biopsy of lymph node

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0193842
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
Descrição

Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0242089
UMLS CUI [1,2]
C0019163
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019196
UMLS CUI [3]
C0019699
known sensitivity or allergy to murine products.
Descrição

Hypersensitivity Product Murine

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1254351
UMLS CUI [1,3]
C0026809
presence or history of central nervous system involvement by lymphoma
Descrição

Central Nervous System Involvement Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0024299
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
Descrição

High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C1861172
UMLS CUI [2,1]
C0199176
UMLS CUI [2,2]
C0558080
UMLS CUI [2,3]
C1861172
any of the following laboratory abnormalities:
Descrição

LABORATORY ABNORMALITIES

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1853129
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
Descrição

Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
Descrição

Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0030274
UMLS CUI [4,3]
C1314939
UMLS CUI [4,4]
C0024299
creatinine clearance of < 30 ml/min
Descrição

Creatinine clearance measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0373595

Similar models

Eligibility Follicular Lymphoma NCT01476787

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
boolean
C0024301 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0432516 (UMLS CUI [2,2])
Systemic therapy Absent Lymphoma
Item
have no prior systemic treatment for lymphoma
boolean
C1515119 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Follicular Lymphoma Symptomatic Treatment required for
Item
symptomatic follicular lymphoma requiring treatment.
boolean
C0024301 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,3])
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Lymphoma transformation | Follicular Lymphoma Grade
Item
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
boolean
C0024299 (UMLS CUI [1,1])
C0040682 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0441800 (UMLS CUI [2,2])
Major surgery | Exception Biopsy of lymph node
Item
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
boolean
C0679637 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0193842 (UMLS CUI [2,2])
Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity
Item
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
boolean
C0242089 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0019699 (UMLS CUI [3])
Hypersensitivity Product Murine
Item
known sensitivity or allergy to murine products.
boolean
C0020517 (UMLS CUI [1,1])
C1254351 (UMLS CUI [1,2])
C0026809 (UMLS CUI [1,3])
Central Nervous System Involvement Lymphoma
Item
presence or history of central nervous system involvement by lymphoma
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism
Item
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
boolean
C0332167 (UMLS CUI [1,1])
C1861172 (UMLS CUI [1,2])
C0199176 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C1861172 (UMLS CUI [2,3])
LABORATORY ABNORMALITIES
Item
any of the following laboratory abnormalities:
boolean
C1853129 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma
Item
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma
Item
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017551 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C0030274 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])
Creatinine clearance measurement
Item
creatinine clearance of < 30 ml/min
boolean
C0373595 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial